Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine

Recent network meta-analyses support the use of pharmacotherapy in patients with generalised anxiety disorder (GAD). Compared with placebo, drug treatment can improve symptoms and quality of life, and is more effective in preventing relapse. Selective serotonin reuptake inhibitors and serotonin–nore...

Descripción completa

Detalles Bibliográficos
Autor principal: Stein, Dan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437845/
https://www.ncbi.nlm.nih.gov/pubmed/34417992
http://dx.doi.org/10.1007/s12325-021-01860-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437845/
https://www.ncbi.nlm.nih.gov/pubmed/34417992
http://dx.doi.org/10.1007/s12325-021-01860-1

Ejemplares similares